“坦白从宽,抗拒从严”,细数“722医药界惨案”中枪的病毒类产品 7月22日,CFDA发布的《国家食品药品监督管理总局关于开展药物临床试验数据自查核查工作的公告(2015年第117号)》号称“史上最严的数据核查要求”,CFDA用了四个”最“来做要求(最严谨的标准、最严格的监管、最严厉的处罚、最严肃的问责),“七二二惨案已经刷爆朋友圈。。撤回还是不撤回,毫无疑问,这对很多医药企业而言将是一个无眠之夜。 公告所附文件附件共列出1622个受理号需要进行自查,并要求在今年8月25日上交自查电子版报告,或者撤回申请,8月25日以后CFDA就会对自查中的疑点进行飞行检查。掐指一算,今天到8月25日只有短短34天时间,对于大多数自查者来说时间非常紧张。笔者总结了1622个产品中的病毒类产品共计67项,分别包括病毒疫苗、血液制品和化学药物。 | | | 重组人乳头瘤病毒(6型,11型,16型,18型)疫苗(酵母) | | | | | | 重组人乳头瘤病毒(6型,11型,16型,18型)疫苗(酵母) | | | | | | | | | | | | | | | | | | | GlaxoSmithKline Biologicals S.A. | | | | | | GlaxoSmithKline Biologicals S.A. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|